Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Thomas G Martin

Showing results (51-60 of 133) with videos related to

Pageof 14
Sort By:
Nature Communications|September 24, 2016
Molecular transport through large-diameter DNA nanoporesSwati Krishnan, Daniela Ziegler, Vera Arnaut, et al.
Leukemia & Lymphoma|February 1, 2017
Phase I/II study of the novel proteasome inhibitor delanzomib (CEP-18770) for relapsed and refractory multiple myelomaDan T Vogl, Thomas G Martin, Ravi Vij, et al.
Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners|October 14, 2021
Evaluation of subcutaneous daratumumab injections in the ambulatory care settingAndrew H Tam, Yoonie Jung, Rebecca Young, et al.
Expert Opinion on Investigational Drugs|May 27, 2025
Emerging GPRC5D-Targeted therapies for multiple myeloma: a comprehensive reviewDarren Pan, Anupama Kumar, Jodi J Lipof, et al.
Journal for Immunotherapy of Cancer|July 17, 2021
Individualized genetic makeup that controls natural killer cell function influences the efficacy of isatuximab immunotherapy in patients with multiple myelomaHaibo Sun, Thomas G Martin, John Marra, et al.
Transplantation and Cellular Therapy|May 27, 2023
Intensity of Cyclophosphamide-Based Bridging Therapy Before Chimeric Antigen Receptor T Cell Therapy in MyelomaAneeqa Zafar, Chiung-Yu Huang, Mimi Lo, et al.
American Journal of Translational Research|August 10, 2023
Peptidyl arginine deiminase inhibition alleviates angiotensin II-induced fibrosisTakeshi Ijichi, Niveda Sundararaman, Thomas G Martin, et al.
Nature Communications|May 20, 2021
Cardiomyocyte contractile impairment in heart failure results from reduced BAG3-mediated sarcomeric protein turnoverThomas G Martin, Valerie D Myers, Praveen Dubey, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 9, 2016
Design of a molecular support for cryo-EM structure determinationThomas G Martin, Tanmay A M Bharat, Andreas C Joerger, et al.
Biorxiv : the Preprint Server for Biology|November 26, 2025
Fiber Type and Stimulus Determine Progression of Skeletal Muscle AtrophyGregory L Maas, Marcus P Mullen, Brooke D Shepard, et al.
Pageof 14

Showing results (51-60 of 133) with videos related to

Sort By:
Pageof 14
Nature Communications|September 24, 2016
Molecular transport through large-diameter DNA nanoporesSwati Krishnan, Daniela Ziegler, Vera Arnaut, et al.
Leukemia & Lymphoma|February 1, 2017
Phase I/II study of the novel proteasome inhibitor delanzomib (CEP-18770) for relapsed and refractory multiple myelomaDan T Vogl, Thomas G Martin, Ravi Vij, et al.
Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners|October 14, 2021
Evaluation of subcutaneous daratumumab injections in the ambulatory care settingAndrew H Tam, Yoonie Jung, Rebecca Young, et al.
Expert Opinion on Investigational Drugs|May 27, 2025
Emerging GPRC5D-Targeted therapies for multiple myeloma: a comprehensive reviewDarren Pan, Anupama Kumar, Jodi J Lipof, et al.
Journal for Immunotherapy of Cancer|July 17, 2021
Individualized genetic makeup that controls natural killer cell function influences the efficacy of isatuximab immunotherapy in patients with multiple myelomaHaibo Sun, Thomas G Martin, John Marra, et al.
Transplantation and Cellular Therapy|May 27, 2023
Intensity of Cyclophosphamide-Based Bridging Therapy Before Chimeric Antigen Receptor T Cell Therapy in MyelomaAneeqa Zafar, Chiung-Yu Huang, Mimi Lo, et al.
American Journal of Translational Research|August 10, 2023
Peptidyl arginine deiminase inhibition alleviates angiotensin II-induced fibrosisTakeshi Ijichi, Niveda Sundararaman, Thomas G Martin, et al.
Nature Communications|May 20, 2021
Cardiomyocyte contractile impairment in heart failure results from reduced BAG3-mediated sarcomeric protein turnoverThomas G Martin, Valerie D Myers, Praveen Dubey, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 9, 2016
Design of a molecular support for cryo-EM structure determinationThomas G Martin, Tanmay A M Bharat, Andreas C Joerger, et al.
Biorxiv : the Preprint Server for Biology|November 26, 2025
Fiber Type and Stimulus Determine Progression of Skeletal Muscle AtrophyGregory L Maas, Marcus P Mullen, Brooke D Shepard, et al.
Pageof 14